PYC Interest Expense from 2010 to 2024

Stocks . Australia . 
Stock . PYC Therapeutics
PYC Stock   1.40  0.05  3.45%   
PYC Therapeutics Interest Expense yearly trend continues to be comparatively stable with very little volatility. Interest Expense is likely to outpace its year average in 2024. Interest Expense is the cost incurred by an entity for borrowed funds, including loans, bonds, or lines of credit. View All Fundamentals
 
Interest Expense  
First Reported
2010-12-31
Previous Quarter
49.2 K
Current Value
51.7 K
Quarterly Volatility
33.3 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check PYC Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among PYC Therapeutics' main balance sheet or income statement drivers, such as Interest Expense of 51.7 K, Cost Of Revenue of 1.5 M or Depreciation And Amortization of 1.1 M, as well as many indicators such as . PYC financial statements analysis is a perfect complement when working with PYC Therapeutics Valuation or Volatility modules.
  
This module can also supplement various PYC Therapeutics Technical models . Check out the analysis of PYC Therapeutics Correlation against competitors.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for PYC Stock Analysis

When running PYC Therapeutics' price analysis, check to measure PYC Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PYC Therapeutics is operating at the current time. Most of PYC Therapeutics' value examination focuses on studying past and present price action to predict the probability of PYC Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PYC Therapeutics' price. Additionally, you may evaluate how the addition of PYC Therapeutics to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY